Georgia M Beasley

19PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 24, 2026
The melanocytic transcriptomic state is independently associated with poor overall survival in patients with metastatic melanoma.

|Feb 03, 2026
Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.

George Ansstas, Karam Khaddour, Sumedha Sudhaman

|Jul 08, 2025
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).

Michael K Wong, Mohammed M Milhem, Joseph J Sacco

|Mar 27, 2025
Opportunities for Discovery Using Neoadjuvant Immune Checkpoint Blockade in Melanoma.

Uma Nair, Emily Rakestraw, Georgia M Beasley

|Feb 19, 2025
GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling.

Nicholas C DeVito, Y-Van Nguyen, Michael Sturdivant

|May 10, 2024
A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression.

Michael P Plebanek, Yue Xue, Y-Van Nguyen

Pageof 4

Frequent Collaborators

5 joint publications

Brent A Hanks

4 joint publications

Nicholas C DeVito

3 joint publications

Y-Van Nguyen

3 joint publications

Balamayooran Theivanthiran